Spotlight on Recent Advances in Huntington Disease

Monday, 28 August 2023

18:00 – 18:45  CEST
12:00 PM
12:45 PM ET

Virtual
CME/CNE

OVERVIEW

This 45-minute roundtable discussion will focus on advances in recognizing and managing Huntington disease chorea, with a particular focus on newer therapies.

FACULTY

AGENDA

TARGET AUDIENCE

This activity is intended for neurologists, primary care physicians, nurse practitioners, nurses, physician assistants, and other clinicians who treat patients with Huntington disease (HD).

GOAL STATEMENT

The goal of this activity is for learners to be better able to update clinicians on the latest advancements in HD, including new findings concerning diagnosis, biomarkers, and therapies.

LEARNING OBJECTIVES

Upon completion of this activity, participants will: Have increased knowledge the [LIST] [ITEM]Recognition of chorea in HD[ITEM]Clinical data for pharmacotherapies for the management of HD chorea [/LIST]Have greater competence in their ability to [LIST] [ITEM]Implement evidence-based care approaches for people with HD chorea[/LIST]

ACCREDITATION STATEMENT

[MEDSCAPE] [JALOGO] In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

[bold] For Physicians [/bold] Medscape, LLC designates this live activity for a maximum of 0.75[bold] [italic] AMA PRA Category 1 Credits™[/italic] [/bold]. Physicians should claim only the credit commensurate with the extent of their participation in the activity. [bold] For Nurses [/bold] Awarded 0.75 contact hour(s) of nursing continuing professional development for RNs and APNs.